My bookmarksSign up free

Commission Implementing Regulation (EU) 2019/150 of 30 January 2019 amending Implementing Regulation (EU) No 686/2012 as regards the rapporteur Member State for the evaluation of the following active substances contained in plant protection products: deltamethrin, diflufenican, epoxiconazole, fluoxastrobin, prothioconazole and tebuconazole (Text with EEA relevance.)

Commission Implementing Regulation (EU) 2019/150 of 30 January 2019 amending Implementing Regulation (EU) No 686/2012 as regards the rapporteur Member State for the evaluation of the following active substances contained in plant protection products: deltamethrin, diflufenican, epoxiconazole, fluoxastrobin, prothioconazole and tebuconazole (Text with EEA relevance.)

Implementing Regulation (EU) 2019/150 · Regulation · 3 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Implementing Regulation (EU) No 686/2012 is amended in accordance with the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union . It shall apply from 30 March 2019.

Supplementary provisions

ANNEXSupplementary provisions

ANNEX The Annex to Implementing Regulation (EU) No 686/2012 is amended as follows: (1) Part A is amended as follows: (a) the entry for Deltamethrin is replaced by the following: Active substance Rapporteur Member State Co-rapporteur Member State ‘Deltamethrin AT’   (b) the entry for Diflufenican is replaced by the following: Active substance Rapporteur Member State Co-rapporteur Member State ‘Diflufenican CZ’   (c) the entry for Fluoxastrobin is replaced by the following: Active substance Rapporteur Member State Co-rapporteur Member State ‘Fluoxastrobin DE’   (d) the entry for Prothioconazole is replaced by the following: Active substance Rapporteur Member State Co-rapporteur Member State ‘Prothioconazole PL’   (2) Part B is amended as follows: (a) the entry for Epoxiconazole is replaced by the following: Active substance Rapporteur Member State Co-rapporteur Member State ‘Epoxiconazole PL’   (b) the entry for Tebuconazole is replaced by the following: Active substance Rapporteur Member State Co-rapporteur Member State ‘Tebuconazole DK’

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next